FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

EUA Revoked After 510(k) Cleared on Zika Assay

Federal Register notice: FDA revokes the Emergency Use Authorization issued to Chembio Diagnostic Systems for the DPP Zika IgM Assay System because th...

Human Drugs

Kite Therapy Approved for Mantle Cell Lymphoma

FDA grants Kite accelerated approval for Tecartus (brexucabtagene autoleucel) for treating adult patients with relapsed or refractory mantle cell lymp...

Human Drugs

Surgical Insufflator/Smoke Evacuator Cleared

FDA clears a Palliare 510(k) for its EVA15 insufflator and smoke evacuation system.

Human Drugs

Taro Pays $205 Million in Generic Price Fixing Settlement

Taro Pharmaceuticals agrees to pay $205 million in criminal fines to resolve charges of conspiring to fix prices for generic drugs.

Federal Register

Info Collection on ICH Good Clinical Practice Guide

Federal Register notice: FDA sends to OMB an information collection extension for an International Council for Harmonization good clinical practice gu...

Federal Register

Pediatric Advisory Panel to Discuss Safety Reviews

Federal Register notice: FDA announces a 9/15 Pediatric Advisory Committee meeting to discuss pediatric-focused safety reviews.

Human Drugs

FDA Proposes Right to Try Summary Rule

FDA proposes a rule establishing deadlines and contents requirements for the annual summary to be submitted by drug sponsors and manufacturers under t...

Human Drugs

FDA Lifts 3 Seladelpar Clinical Holds

FDA lifts clinical holds for trials of three potential indications for CymaBay Therapeutics seladelpar.

Medical Devices

Abbott Patient Controller Approved on iPhone

FDA approves an Abbott PMA to allow use of the companys Patient Controller app on compatible personal Apple smartphone devices.

Human Drugs

Jazz NDA for Daytime Sleepiness Approved

FDA approves a Jazz Pharmaceuticals NDA for Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution for treating cataplexy or excessi...